Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Doreen Ezeife"'
Publikováno v:
Current Oncology, Vol 29, Iss 6, Pp 3962-3982 (2022)
On behalf of the Canadian Association of Medical Oncologists, we are pleased to present the abstracts of the 2022 Annual Meeting. The CAMO Virtual Annual Scientific Meeting (ASM) took place on 28 April 2022. Twenty-five (25) abstracts were selected f
Externí odkaz:
https://doaj.org/article/bfa11c2ad10045b9aac87f6d793fb628
Autor:
Ellen Cusano, Chelsea Wong, Eddy Taguedong, Marcus Vaska, Tasnima Abedin, Nancy Nixon, Safiya Karim, Patricia Tang, Daniel Y. C. Heng, Doreen Ezeife
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 4894-4928 (2021)
In the era of rapid development of new, expensive cancer therapies, value frameworks have been developed to quantify clinical benefit (CB). We assessed the evolution of CB since the 2015 introduction of The American Society of Clinical Oncology and T
Externí odkaz:
https://doaj.org/article/e8bdd00222fe45b39718365154b929ed
Autor:
Nancy A, Nixon, Omar F, Khan, Hasiba, Imam, Patricia A, Tang, Jose, Monzon, Haocheng, Li, Gavin, Sun, Doreen, Ezeife, Sunil, Parimi, Scot, Dowden, Vincent C, Tam
Publikováno v:
Cancer. 123(23)
Understanding the drug development pathway is critical for streamlining the development of effective cancer treatments. The objective of the current study was to delineate the drug development timeline and attrition rate of different drug classes for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dd543f91e81591d358dbe3f4d83fb525
https://pubmed.ncbi.nlm.nih.gov/28817175
https://pubmed.ncbi.nlm.nih.gov/28817175
Autor:
Cheng S; Sierra Cheng, Erica J. McDonald, Matthew C. Cheung, Vanessa S. Arciero, Mahin Qureshi, Di Jiang, Natasha Leighl, and Kelvin K.W. Chan, University of Toronto; Mona Sabharwal, Alexandra Chambers, Dolly Han, and Kelley-Anne Sabarre, Canadian Agency for Drugs and Technologies in Health; Kelvin K.W. Chan, Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario; and Doreen Ezeife, University of Calgary, Calgary, Alberta, Canada., McDonald EJ; Sierra Cheng, Erica J. McDonald, Matthew C. Cheung, Vanessa S. Arciero, Mahin Qureshi, Di Jiang, Natasha Leighl, and Kelvin K.W. Chan, University of Toronto; Mona Sabharwal, Alexandra Chambers, Dolly Han, and Kelley-Anne Sabarre, Canadian Agency for Drugs and Technologies in Health; Kelvin K.W. Chan, Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario; and Doreen Ezeife, University of Calgary, Calgary, Alberta, Canada., Cheung MC; Sierra Cheng, Erica J. McDonald, Matthew C. Cheung, Vanessa S. Arciero, Mahin Qureshi, Di Jiang, Natasha Leighl, and Kelvin K.W. Chan, University of Toronto; Mona Sabharwal, Alexandra Chambers, Dolly Han, and Kelley-Anne Sabarre, Canadian Agency for Drugs and Technologies in Health; Kelvin K.W. Chan, Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario; and Doreen Ezeife, University of Calgary, Calgary, Alberta, Canada., Arciero VS; Sierra Cheng, Erica J. McDonald, Matthew C. Cheung, Vanessa S. Arciero, Mahin Qureshi, Di Jiang, Natasha Leighl, and Kelvin K.W. Chan, University of Toronto; Mona Sabharwal, Alexandra Chambers, Dolly Han, and Kelley-Anne Sabarre, Canadian Agency for Drugs and Technologies in Health; Kelvin K.W. Chan, Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario; and Doreen Ezeife, University of Calgary, Calgary, Alberta, Canada., Qureshi M; Sierra Cheng, Erica J. McDonald, Matthew C. Cheung, Vanessa S. Arciero, Mahin Qureshi, Di Jiang, Natasha Leighl, and Kelvin K.W. Chan, University of Toronto; Mona Sabharwal, Alexandra Chambers, Dolly Han, and Kelley-Anne Sabarre, Canadian Agency for Drugs and Technologies in Health; Kelvin K.W. Chan, Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario; and Doreen Ezeife, University of Calgary, Calgary, Alberta, Canada., Jiang D; Sierra Cheng, Erica J. McDonald, Matthew C. Cheung, Vanessa S. Arciero, Mahin Qureshi, Di Jiang, Natasha Leighl, and Kelvin K.W. Chan, University of Toronto; Mona Sabharwal, Alexandra Chambers, Dolly Han, and Kelley-Anne Sabarre, Canadian Agency for Drugs and Technologies in Health; Kelvin K.W. Chan, Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario; and Doreen Ezeife, University of Calgary, Calgary, Alberta, Canada., Ezeife D; Sierra Cheng, Erica J. McDonald, Matthew C. Cheung, Vanessa S. Arciero, Mahin Qureshi, Di Jiang, Natasha Leighl, and Kelvin K.W. Chan, University of Toronto; Mona Sabharwal, Alexandra Chambers, Dolly Han, and Kelley-Anne Sabarre, Canadian Agency for Drugs and Technologies in Health; Kelvin K.W. Chan, Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario; and Doreen Ezeife, University of Calgary, Calgary, Alberta, Canada., Sabharwal M; Sierra Cheng, Erica J. McDonald, Matthew C. Cheung, Vanessa S. Arciero, Mahin Qureshi, Di Jiang, Natasha Leighl, and Kelvin K.W. Chan, University of Toronto; Mona Sabharwal, Alexandra Chambers, Dolly Han, and Kelley-Anne Sabarre, Canadian Agency for Drugs and Technologies in Health; Kelvin K.W. Chan, Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario; and Doreen Ezeife, University of Calgary, Calgary, Alberta, Canada., Chambers A; Sierra Cheng, Erica J. McDonald, Matthew C. Cheung, Vanessa S. Arciero, Mahin Qureshi, Di Jiang, Natasha Leighl, and Kelvin K.W. Chan, University of Toronto; Mona Sabharwal, Alexandra Chambers, Dolly Han, and Kelley-Anne Sabarre, Canadian Agency for Drugs and Technologies in Health; Kelvin K.W. Chan, Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario; and Doreen Ezeife, University of Calgary, Calgary, Alberta, Canada., Han D; Sierra Cheng, Erica J. McDonald, Matthew C. Cheung, Vanessa S. Arciero, Mahin Qureshi, Di Jiang, Natasha Leighl, and Kelvin K.W. Chan, University of Toronto; Mona Sabharwal, Alexandra Chambers, Dolly Han, and Kelley-Anne Sabarre, Canadian Agency for Drugs and Technologies in Health; Kelvin K.W. Chan, Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario; and Doreen Ezeife, University of Calgary, Calgary, Alberta, Canada., Leighl N; Sierra Cheng, Erica J. McDonald, Matthew C. Cheung, Vanessa S. Arciero, Mahin Qureshi, Di Jiang, Natasha Leighl, and Kelvin K.W. Chan, University of Toronto; Mona Sabharwal, Alexandra Chambers, Dolly Han, and Kelley-Anne Sabarre, Canadian Agency for Drugs and Technologies in Health; Kelvin K.W. Chan, Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario; and Doreen Ezeife, University of Calgary, Calgary, Alberta, Canada., Sabarre KA; Sierra Cheng, Erica J. McDonald, Matthew C. Cheung, Vanessa S. Arciero, Mahin Qureshi, Di Jiang, Natasha Leighl, and Kelvin K.W. Chan, University of Toronto; Mona Sabharwal, Alexandra Chambers, Dolly Han, and Kelley-Anne Sabarre, Canadian Agency for Drugs and Technologies in Health; Kelvin K.W. Chan, Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario; and Doreen Ezeife, University of Calgary, Calgary, Alberta, Canada., Chan KKW; Sierra Cheng, Erica J. McDonald, Matthew C. Cheung, Vanessa S. Arciero, Mahin Qureshi, Di Jiang, Natasha Leighl, and Kelvin K.W. Chan, University of Toronto; Mona Sabharwal, Alexandra Chambers, Dolly Han, and Kelley-Anne Sabarre, Canadian Agency for Drugs and Technologies in Health; Kelvin K.W. Chan, Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario; and Doreen Ezeife, University of Calgary, Calgary, Alberta, Canada.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2017 Aug 20; Vol. 35 (24), pp. 2764-2771. Date of Electronic Publication: 2017 Jun 02.